Fetal and placental cyclic inositol phosphohydrolase in normoxia and hypoxia.
Cyclic inositol phosphohydrolase (cIPH) converts cyclic inositol monophosphate (cIP), a putative modulator of cell growth, into inositol monophosphate. We hypothesized that hypoxic-ischemic injury alters cIPH activity in the placenta. On the 29th day of gestation pregnant rabbits were randomized to either 50 min of uterine ischemia (hypoxia) or no ischemia (controls). The activity of cIPH was measured by incubating with [3H]cIP and determining the release of [3H]inositol. Although no cIPH has been demonstrated in blood previously, cIPH activity was found in both fetal and maternal blood. cIPH activity was higher on the fetal side of the placenta than on the maternal side and was also higher in fetal blood compared to maternal blood. Hypoxia-ischemia failed to alter the cIPH activity in fetal blood and fetal and maternal placenta. Since cIPH activity is higher in the fetus and is retained even after major ischemia, modulation of cIP may be important in early development.
Department of Pediatrics, University of Alabama at Birmingham, AL 35233-7335, USA. sid.tan@ccc.uab.edu
S
S
Tan
M C
MC
Sekar
D000818:Animals; D017318:Annexin A3 / Q000097:blood*; D005260:Female; D005312:Fetal Blood / Q000201:enzymology*; D005311:Fetal Hypoxia / Q000201:enzymology*; D007295:Inositol Phosphates / Q000378:metabolism; D007511:Ischemia; D007700:Kinetics; D010920:Placenta / Q000098:blood supply*; D011247:Pregnancy; D011817:Rabbits; D014599:Uterus / Q000098:blood supply
D007295:Inositol Phosphates; C010199:inositol cyclic phosphate; D017318:Annexin A3